Ventas CEO Debra Cafaro Has Filed 2,617 Insider Transactions and Sold $280 Million in VTR Stock
Debra Cafaro, the longtime CEO of healthcare REIT Ventas, has sold $280 million across 2,617 insider transactions since her tenure began, making her one of the most active CEO sellers in the REIT sector.
Debra Cafaro, chairman and CEO of Ventas (VTR), has filed 2,617 insider transactions since the early 2000s — selling $280 million and purchasing $499,000 in company stock. As one of the longest-tenured CEOs in the real estate investment trust (REIT) sector, Cafaro's two-decade filing record offers a detailed map of executive monetization at a major healthcare property owner.
The Numbers
| Metric | Value |
|---|---|
| Career Sell Value | $280 million |
| Career Buy Value | $499,245 |
| Total Transactions | 2,617 |
| Last Transaction | Dec 1, 2025 |
| Companies Filed Under | 1 |
What It Means
Cafaro joined Ventas as CEO in 1999 when the company was a small healthcare REIT with a $200 million market cap. Under her leadership, Ventas grew into a $24 billion enterprise through aggressive acquisitions of senior housing, medical office, and research properties. Her $280 million in insider sales represents systematic monetization over 25+ years — a pattern consistent with long-tenured executives who build wealth primarily through equity compensation rather than a founding stake.
The $499,000 in career purchases, while modest compared to her sells, is notable because it represents discretionary capital deployed at prices she believed were attractive. REIT executives rarely buy on the open market because their compensation is heavily weighted toward restricted stock units, making any voluntary purchase an unusually strong signal of confidence.
Cafaro's filing record of 2,617 transactions also reflects the complexity of REIT executive compensation — vesting schedules, dividend reinvestment plans, and quarterly equity awards generate far more filings than comparable positions at non-REIT companies.
What to Watch
- Whether Cafaro resumes open-market purchases at current VTR prices near $65, which would echo her earlier discretionary buying activity
- Ventas's senior housing recovery narrative — occupancy rates have been climbing post-pandemic, which has been the primary stock catalyst
- Any succession planning signals: Cafaro has led Ventas for over 25 years, and changes to her compensation structure or role could affect the filing pattern
Related Research
Explore all researchOvata Capital's Q4 2025 filing is one of the strangest and most revealing in the cycle: Spotify calls at the top, Ryanair and TSMC right behind, IBIT in the top four, and multiple option-heavy special-situation lines throughout the book.
Mar 6, 2026
Ameriprise Financial's 11,224-position portfolio has the lowest top-5 concentration of any mega-filer at 14.8%. Netflix shares surged 943%, confirming an institutional consensus trade across $2.7 trillion in combined AUM. Salesforce built 82%.
Mar 6, 2026
SHP Wealth Management's Q4 2025 13F is one of the clearest ETF-model portfolios in the dataset: VOO at 27.4%, income and duration sleeves in the top five, and no meaningful stock-picking noise at the top.
Mar 6, 2026
Oak Grove Capital's Q4 2025 13F is one of the clearest concentration statements in the database: Micron at 26.5%, NVIDIA at 23.7%, and a top-five bucket worth 61.3% of the whole filing.
Mar 6, 2026
NWF Advisory Services built a blended portfolio in Q4 2025: Berkshire for quality, XLK for tech beta, VOO and IVV for benchmark exposure, and a fast-rising Micron line for a more specific semiconductor view.
Mar 6, 2026